Post-COVID-19, India needs to strengthen its pharma R&D ecosystem to tap into emerging drug development opportunities and changing paradigms in the new drug development framework.....

Though a new guideline released by the General Office of the State Council, China has revised the registration and approval of pharmaceutical products to fasten the process, the implementation still n...